Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Qin

Showing results (361-370 of 539) with videos related to

Pageof 54
Sort By:
The Journal of Experimental Medicine|November 2, 1999
Human G protein-coupled receptor GPR-9-6/CC chemokine receptor 9 is selectively expressed on intestinal homing T lymphocytes, mucosal lymphocytes, and thymocytes and is required for thymus-expressed chemokine-mediated chemotaxisB A Zabel, W W Agace, J J Campbell, et al.
Genomics|November 15, 1994
A YAC contig spanning the ataxia-telangiectasia locus (groups A and C) at 11q22-q23G Rotman, K Savitsky, Y Ziv, et al.
Cell Death & Disease|November 16, 2013
Jun dimerization protein 2 is a critical component of the Nrf2/MafK complex regulating the response to ROS homeostasisS Tanigawa, C H Lee, C S Lin, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 11, 2021
Plasma Metabolic Phenotypes of HPV-Associated versus Smoking-Associated Head and Neck Cancer and Patient SurvivalRonald C Eldridge, Karan Uppal, D Neil Hayes, et al.
ESMO Open|May 28, 2025
Health-related quality of life analysis of the LEAP-002 study of lenvatinib plus pembrolizumab versus lenvatinib as first-line treatment for advanced hepatocellular carcinomaR S Finn, M Kudo, P Merle, et al.
Stem Cell Reports|June 25, 2019
Rapid Irreversible Transcriptional Reprogramming in Human Stem Cells Accompanied by Discordance between Replication Timing and Chromatin CompartmentVishnu Dileep, Korey A Wilson, Claire Marchal, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 25, 2015
First-line erlotinib versus gemcitabine/cisplatin in patients with advanced EGFR mutation-positive non-small-cell lung cancer: analyses from the phase III, randomized, open-label, ENSURE studyY-L Wu, C Zhou, C-K Liam, et al.
Journal for Immunotherapy of Cancer|May 9, 2025
Blocking LIF and PD-L1 enhances the antitumor efficacy of SBRT in murine PDAC modelsJian Ye, Shuyang S Qin, Angela L Hughson, et al.
Scientific Reports|April 22, 2017
Identifying tagging SNPs for African specific genetic variation from the African Diaspora GenomeHenry Richard Johnston, Yi-Juan Hu, Jingjing Gao, et al.
Genome Research|July 5, 2011
Deep sequencing reveals distinct patterns of DNA methylation in prostate cancerJung H Kim, Saravana M Dhanasekaran, John R Prensner, et al.
Pageof 54

Showing results (361-370 of 539) with videos related to

Sort By:
Pageof 54
The Journal of Experimental Medicine|November 2, 1999
Human G protein-coupled receptor GPR-9-6/CC chemokine receptor 9 is selectively expressed on intestinal homing T lymphocytes, mucosal lymphocytes, and thymocytes and is required for thymus-expressed chemokine-mediated chemotaxisB A Zabel, W W Agace, J J Campbell, et al.
Genomics|November 15, 1994
A YAC contig spanning the ataxia-telangiectasia locus (groups A and C) at 11q22-q23G Rotman, K Savitsky, Y Ziv, et al.
Cell Death & Disease|November 16, 2013
Jun dimerization protein 2 is a critical component of the Nrf2/MafK complex regulating the response to ROS homeostasisS Tanigawa, C H Lee, C S Lin, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 11, 2021
Plasma Metabolic Phenotypes of HPV-Associated versus Smoking-Associated Head and Neck Cancer and Patient SurvivalRonald C Eldridge, Karan Uppal, D Neil Hayes, et al.
ESMO Open|May 28, 2025
Health-related quality of life analysis of the LEAP-002 study of lenvatinib plus pembrolizumab versus lenvatinib as first-line treatment for advanced hepatocellular carcinomaR S Finn, M Kudo, P Merle, et al.
Stem Cell Reports|June 25, 2019
Rapid Irreversible Transcriptional Reprogramming in Human Stem Cells Accompanied by Discordance between Replication Timing and Chromatin CompartmentVishnu Dileep, Korey A Wilson, Claire Marchal, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 25, 2015
First-line erlotinib versus gemcitabine/cisplatin in patients with advanced EGFR mutation-positive non-small-cell lung cancer: analyses from the phase III, randomized, open-label, ENSURE studyY-L Wu, C Zhou, C-K Liam, et al.
Journal for Immunotherapy of Cancer|May 9, 2025
Blocking LIF and PD-L1 enhances the antitumor efficacy of SBRT in murine PDAC modelsJian Ye, Shuyang S Qin, Angela L Hughson, et al.
Scientific Reports|April 22, 2017
Identifying tagging SNPs for African specific genetic variation from the African Diaspora GenomeHenry Richard Johnston, Yi-Juan Hu, Jingjing Gao, et al.
Genome Research|July 5, 2011
Deep sequencing reveals distinct patterns of DNA methylation in prostate cancerJung H Kim, Saravana M Dhanasekaran, John R Prensner, et al.
Pageof 54